KLTO
Klotho Neurosciences, Inc.
NASDAQ: KLTO · HEALTHCARE · BIOTECHNOLOGY
$0.52
+0.00% today
Updated 2026-04-30
Market cap
$56.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
9.5M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.09M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-1.11M | $-598593.00 | $-707458.00 | $-6.15M | $-2.90M |
| EPS | — | — | — | — | $-0.30 |
| Free cash flow | $-284021.00 | $-724981.00 | $-460804.00 | $-3.07M | $-1.09M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Klotho Neurosciences, Inc. trades at $0.52. Our Smart Value Score of 16/100 indicates the stock is weak.
Frequently asked questions
What is Klotho Neurosciences, Inc.'s stock price?
Klotho Neurosciences, Inc. (KLTO) trades at $0.52.
Is Klotho Neurosciences, Inc. overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Klotho Neurosciences, Inc. (KLTO)?
The analyst target price is $—, representing NaN% downside from the current price of $0.52.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-198.30%
Beta2.24
50D MA$0.34
200D MA$0.65
Shares out0.11B
Float0.07B
Short ratio—
Avg volume9.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—